Abstract
Two clinical cases presented, of the patients with hypertrophic cardiomyopathy and individualized pulse reduction therapy approach. Patients were prescribed consequently bisoprolol and ivabradine (Coraxan®, “Les Laboratoires Servier”, France) with comparative efficacy assessment by a complex investigation that included EchoCG, exercise tests, 24-hour monitoring of ECG and BP.
Author supplied keywords
Cite
CITATION STYLE
Krylova, N. S., Kovalevskaya, E. A., Poteshkina, N. G., Mershina, E. A., Sinitsyn, V. E., Sonicheva, N. A., & Monserrat, L. (2017). Pulse reduction in management of hypertrophic cardiomyopathy (Two clinical cases). Russian Journal of Cardiology, 152(12), 104–112. https://doi.org/10.15829/1560-4071-2017-12-104-112
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
